We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

MGI Tech Co., Ltd.

MGI Tech Co., Ltd. produces sequencing instruments, reagents, equipment and related products to support life science ... read more Featured Products: More products

Download Mobile App





MGI Launches New Gene Sequencing Platforms at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023
Print article
Image: The new NBSEQ-G99 gene sequencer with mid to low range throughput (Photo courtesy of MGI)
Image: The new NBSEQ-G99 gene sequencer with mid to low range throughput (Photo courtesy of MGI)

MGI Tech Co. Ltd. (Shenzhen, China) is introducing its latest gene sequencing platforms at Medlab Middle East 2023, taking place 6-9 February in Dubai. The three new products being launched at Medlab Middle East by MGI includes DNBSEQ-G99, its latest gene sequencer with a mid to low range throughput, DNBSEQ-E25, a portable sequencer with a very low throughput, the DNBelab-D4 digital sample preparation system. In addition, the company is also displaying its MGISP-100 automated sample preparation system for visitors at its booth.

As one of the sequencers with the fastest speed among those with the same throughput in the world, DNBSEQ-G99 is based on MGI's core DNBSEQTM sequencing technology. It is the first sequencer to adopt triangular matrix signal spots on sequencing flow cell, among other innovations in biochemistry, optics, fluidics, temperature control and more, reaching higher density of data output, with an overall throughput of 8-48 Gb per run. DNBSEQ-G99 is especially suitable for targeted gene sequencing and small genome sequencing, requiring only 12 hours to finish PE150 sequencing.

DNBSEQ-E25, the flagship product in the E-series, is a portable, accessible, and user-friendly sequencer that features a data throughput of up to 7.5G daily. Built on the newly designed self-luminous biochemical system, DNBSEQ-E25 has upgraded its sequencing system, flowcells and sequencing cartridge. Equipped with built-in bioinformatics, it is designed to run sequencing and generate analysis reports on the go. Its ease of setup means it is ready to run in ten minutes, coupled by a quick turnaround time that takes only 20 hours from sample to FASTQ data.

Lastly, DNBelab-D4 is the first digital microfluidic automation platform developed by MGI. The portable digital sample preparation system can prepare samples from DNA to DNB on a single sample prep card. Meanwhile, it integrates the quantification function for automatic quantification after DNB preparation is completed, eliminating the need for manual quantification. Currently, DNBelab-D4 is mainly used for library preparation for high-throughput sequencing applications such as metagenomics sequencing of unknown pathogens. It can also cater to the requirements of different research and medical applications.

"We are excited to launch three new products at MEDLAB Middle East, including DNBSEQ-G99, our latest model of gene sequencer with mid to low range throughput, DNBSEQ-E25, a portable sequencer with very low throughput, as well as DNBelab-D4 digital sample preparation system. In addition, our MGISP-100 automated sample preparation system will be on display for visitors interested to learn more," said Dr. Roy Tan, General Manager of MGI Asia Pacific. "Once again, MGI showcases the commitment to supporting healthcare, scientific research and applications across the Middle East through our genomic technologies."

Related Links:
MGI Tech Co. Ltd.

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The breakthrough could result in a higher success rate using a simple oral swab test before IVF (Photo courtesy of Shutterstock)

POC Oral Swab Test to Increase Chances of Pregnancy in IVF

Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.